Written by: Alex Green
Surfer Blood’s guitarist Thomas Fekete elaborated today on the cancer that has forced him to leave the West Palm Beach band.
On his GoFundMe page, which can be found here, Fekete explains:
“A few months back I had a major surgery to remove a large tumor from my abdomen. I was diagnosed with a very rare and aggressive cancer (a sarcoma), which unfortunately has moved. A few days ago, my doctors informed me that it had spread to my lungs and my spine. The lesion on my lower spine will be treated with radiation, and I’ll also start chemotherapy this week. Because my cancer is so rare, there is very little research on it (cancer treatment is a business after all), so going to a typical doctor and getting loaded with all types of drugs would probably kill me. However, I found a doctor who is on the cutting edge of cancer treatments, and we have assembled a team of brilliant doctors who all seem to be extremely confident in an alternative treatment plan, to complement the chemotherapy. Because these doctors are doing things a bit differently, insurance will only cover a portion of my treatment. I never in my life thought that I would be asking for money publicly, but the universe works in funny ways.”
Because he has left the band and is unable to tour, Fekete could use some help with his mounting medical bills.
“Any bit of help would be massive for me,” he writes. “…My wonderful wife/best friend whom I just married in November will now be leaving work to help me throughout my treatment. If you can’t help, no worries whatsoever, all I ask is that you spread the word. Any extra funds collected when this is all said and done will be donated to further my doctor’s alternative cancer research. I not only feel great, but I am in great spirits, and I know this will soon be over like a bad dream. Please take care of yourselves, enjoy every single day. Life is beautiful. Love and light always…”
Surfer Blood released their debut album Astro Coast back in 2010.
Their latest effort is 1000 Palms and it will be out May 15.
